Table 1. Baseline Characteristics of Total Sample and by MetSyn Improvement Group.
| Characteristics | Total (N=116) Mean (SD), Range | Improved (n=33) Mean (SD), Range | No Improvement (n=83) Mean (SD), Range |
|---|---|---|---|
| Age | 67.5 (8.4), 55-89 | 66.7 (8.8), 55-83 | 67.9 (8.3), 55-89 |
| Male | 86 (74.4%) | 24 (72.7%) | 62 (74.7%) |
| White | 108 (93.1%) | 31(93.9%) | 76 (91.6%) |
| Minority | 8 (6.9) | 2 (6.1%) | 6 (8.1%) |
| Years of education | 15.4 (2.8), 11-24 | 14.8 (2.7), 12-20 | 15.3 (2.9), 11-24 |
| Employed | 49 (42.2%) | 19 (57.6%) | 30 (36.1%) |
| Not employed | 67 (57.8%) | 14 (42.4%) | 53 (63.9%) |
| NHYA classification | |||
| Class I | 97 (83.6%) | 28 (84.9%) | 69 (83.3%) |
| Class II | 10 (8.6%) | 3 (9.1%) | 7 (8.4%) |
| Class II | 8 (6.9%) | 1 (3.0%) | 7 (8.4%) |
| Class IV | 1 (.09%) | 1 (3.0%) | 0 (0.0%) |
| Chronic conditions | |||
| Hypertension | 113 (97.4%) | 32 (96.9%) | 81 (97.6%) |
| Obesity | 40 (34.5%) | 11 (33.3%) | 29 (34.9%) |
| Arthritis | 36 (31.0%) | 11 (33.3%) | 25 (30.1%) |
| Diabetes | 29 (25.0%) | 3 (9.1%) | 26 (31.3%) |
| HR* -attenuating medications | 102 (88%) | 29 (87%) | 73 (88%) |
| 6-minute work test | 1100 (1120) | 1170 (306) | 1100 (265) |
*
HR= heart rate